Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

A plea for clear language on vaccine safety

Noni MacDonald and André Picard
CMAJ March 31, 2009 180 (7) 697-698; DOI: https://doi.org/10.1503/cmaj.090363
Noni MacDonald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Picard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

“If you can't explain it simply, you don't understand it well enough.” — Albert Einstein

Most academics see their fellow academics as the main audience for their scientific work. But the Web and search engines such as Google have made academic articles and reports widely accessible. This new-found availability can be problematic. The careful, precise aca demic language that is the backbone of scientific writing — the language of scholarly articles and reports — can lead nonacademics to draw incorrect conclusions about the information being presented. The academic literature about vaccine safety provides some powerful examples of the troubling gap between academic intent and public conclusions.

Immunization against childhood diseases is one of medicine's greatest achievements, having prevented millions of deaths and disabilities. But the very success of vaccination has had unintended consequences. The public has little or no personal knowledge about the consequences of these once terrible vaccine-preventable diseases and now pays far more attention to concerns about vaccine safety. Many of these concerns have been greatly exaggerated.1

Although much has been written about the importance of providing information about the risks of diseases and the benefits and safety of vaccines in clear language on consent forms for vaccination, little attention has been paid to the same need for clarity in the language of scientific reports and academic articles. In the wired world, the audience for these articles includes the media, politicians, the general public, vaccine supporters, antivaccine lobbyists and health care workers. The cautious, exact scientific language of academic articles is largely alien to many members of these groups and can obscure the meaning of the scientific findings and fuel misinformation.

The conclusion in the executive summary of the 2001 Institute of Medicine report about the relation between the measles–mumps–rubella vaccine and autism2 provides an excellent example of potentially confusing academic language (Box 1). This conclusion was carefully crafted in precise academic language — so precise that, depending on the reader, different conclusions can be drawn. The academic involved in vaccine research, familiar with the scientific principle that the null hypothesis cannot be proven, would conclude that this report does not find evidence that the measles–mumps–rubella vaccine causes autism. A health care worker reading this same statement may not be sure what to make of it: maybe the vaccine causes autism in some children, just not often. The politician may wonder whether supporting public programs for measles–mumps–rubella vaccination at this time is justified. The journalist may reasonably interpret the conclusion as saying that the vaccine is a cause of autism, albeit an infrequent one. The antivaccine lobby, for its part, would be delighted that this respected academic body has given support to its claims that the vaccine can cause autism. Contrast the statements in Box 1 with those in Box 2, which presents our summary of the same conclusion in clear language.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 2.

Unclear meanings are not just an issue for academic articles and reports about vaccine safety. When a serious adverse event follows vaccination, the patient, caregiver, program provider and members of the general public rightfully want to know: Did the vaccine cause the serious event or was this just a coincidence? Rigorous studies to determine whether one event caused another follow a formal scientific process.3–5 Once these are completed, the relation between the vaccine and the serious event is reported as very likely or certain, probable, possible, unlikely, unrelated or unclassifiable.4 For scientific precision, the term “unlikely” is used when there is no evidence that the vaccine caused the event but no firm evidence for another cause. From a scientific perspective, the event cannot be classified as “unrelated,” because this is unproven. Ironically, the term “unlikely” may imply the opposite to nonacademics — that there is a causal association between the adverse event and the vaccine administered.

Such serious misunderstandings, whether by health care workers, community members, politicians or journalists, can lead to a widespread community belief that the vaccine in question is unsafe. Instead of calming fears, the misinterpreted conclusion may add to anxiety. The vaccine program may be stopped as a result, leading to a rise in the incidence of the disease and, in some instances, deaths and disabilities that could have been prevented by vaccination. Some developing countries have made a plea that the outcomes of vaccine causality assessments be reported in clear language that cannot be misinterpreted (i.e., a statement that the vaccine either did or did not cause the adverse event).

The harms that can occur when academic language obscures meaning are serious and will only increase if we do not improve our communication skills. Academic jargon that obscures meaning must be replaced by crisp, understandable conclusions. We know that this will not be easy. All medical academics should receive formal education about how to write in a clear and straightforward manner and why this is important. We urge all academic writers, medical journal editors and reviewers of academic reports to ensure that the meaning of an article's conclusion or a report's summary is clear and cannot be misinterpreted.

Footnotes

  • With the Editorial-Writing Team (Paul C. Hébert MD MHSc, Matthew B. Stanbrook MD PhD and Ken Flegel MDCM MSc)

    Competing interests: See www.cmaj.ca/misc/edboard.shtml for the Editorial-Writing Team's statements. None declared for André Picard.

REFERENCES

  1. 1.↵
    Fisher MC. Vaccine safety. Pediatr Infect Dis J 2008;27:827-30.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Stratton K, Gable A, Shetty P, et al., editors; Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee. Immunization safety review: measles–mumps–rubella vaccine and autism. Washington (DC): National Academies Press; 2001.
  3. 3.↵
    World Health Organization Global Advisory Committee on Vaccine Safety. Causality assessment of adverse events following immunization. Wkly Epidemiol Rec 2001;76:85-9.
    OpenUrlPubMed
  4. 4.↵
    World Health Organization. Adverse events following immunization (AEFI): causality assessment. Aide memoire. Geneva (Switzerland): The Organization. Available: www.who.int/vaccines-documents/DocsPDF05/815.pdf (accessed 2009 Feb. 25).
  5. 5.↵
    Collet JP, MacDonald N, Cashman N, et al.; Advisory Committee on Causality Assessment. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Bull World Health Organ 2000;78:178-85.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 180 (7)
CMAJ
Vol. 180, Issue 7
31 Mar 2009
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A plea for clear language on vaccine safety
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A plea for clear language on vaccine safety
Noni MacDonald, André Picard
CMAJ Mar 2009, 180 (7) 697-698; DOI: 10.1503/cmaj.090363

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A plea for clear language on vaccine safety
Noni MacDonald, André Picard
CMAJ Mar 2009, 180 (7) 697-698; DOI: 10.1503/cmaj.090363
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Trouver, tester, « tracer » et isoler énergiquement pour battre la COVID-19
  • Intégration des essais randomisés dans les soins cliniques : comment le Canada peut faire mieux
  • Soins continus et COVID-19 : Qu’une telle tragédie ne se reproduise plus au Canada!
Show more Éditorial

Similar Articles

Collections

  • Topics
    • Medical education, residency, internship
    • Journalology & publication ethics

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire